Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease

BMC Complementary and Alternative Medicine
Wei MaoXusheng Liu

Abstract

Chronic kidney disease (CKD) is a global public health problem. Currently, as for advanced CKD populations, medication options limited in angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB), which were partially effective. A Chinese herbal compound, Bupi Yishen formula, has showed renal protective potential in experiments and retrospective studies. This study will evaluate the efficacy and safety of Bupi Yishen formula (BYF) in patients with CKD stage 4. In this double blind, double dummy, randomized controlled trial (RCT), there will be 554 non-diabetes stage 4 CKD patients from 16 hospitals included and randomized into two groups: Chinese medicine (CM) group or losartan group. All patients will receive basic conventional therapy. Patients in CM group will be treated with BYF daily while patients in control group will receive losartan 100 mg daily for one year. The primary outcome is the change in estimated glomerular filtration rate (eGFR) over 12 months. Secondary outcomes include the incidence of endpoint events, liver and kidney function, urinary protein creatinine ratio, cardiovascular function and quality of life. This study will be the first multi-center, double blind RCT to assess wh...Continue Reading

References

Jan 13, 2006·The New England Journal of Medicine·Fan Fan HouRen Wen Geng
Nov 9, 2006·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·UNKNOWN Chinese Association of Integrative Medicine, Liver Disease Committee
Dec 13, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S LeveyJoel D Kopple
Jan 11, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·LuXia ZhangHaiYan Wang
Apr 10, 2007·Journal of Ethnopharmacology·Yong Gyu LeeJae Youl Cho
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Jul 22, 2008·International Journal of Biological Macromolecules·Sun Yongxu, Liu Jicheng
Nov 8, 2008·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Yong-jun WangChong-jian Zhou
Nov 17, 2009·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Guan-jun PuLi-qun He
Jan 8, 2010·The New England Journal of Medicine·Hanna Abboud, William L Henrich
May 26, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Faruk TurgutEmaad M Abdel-Rahman
Oct 19, 2010·Journal of Ethnopharmacology·Mingxin LiShanyan Lin
Jan 29, 2014·The American Journal of Chinese Medicine·Jung-Chun LiaoWen-Huang Peng
Jun 3, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Guo-Jun ZhouTong-Shui Zhou

❮ Previous
Next ❯

Software Mentioned

SAS
PASS
Interactive Web Response System for Chinese Medicine Trials ( ...
PAWS
SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.